Kathleen A. Cote
Known title: DirectorCIK: 0001181540
Associated companies
Transaction History
| VRSN | ▲ Buy | Grant | 900 | $0 | 7/20/2026 | View on chart |
| VRSN | ▲ Buy | Grant | 879 | $0 | 7/21/2025 | View on chart |
| VRSN | ▼ Sell | Open Market | 3,000 | $690K | 2/18/2025 | View on chart |
| VRSN | ▲ Buy | Grant | 1,408 | $0 | 7/22/2024 | View on chart |
| VRSN | ▲ Buy | Grant | 1,179 | $0 | 7/24/2023 | View on chart |
| VRSN | ▼ Sell | Open Market | 1,000 | $224K | 5/3/2023 | View on chart |
| VRSN | ▼ Sell | Open Market | 2,665 | $541K | 2/21/2023 | View on chart |
| VRSN | ▲ Buy | Grant | 1,377 | $0 | 7/25/2022 | View on chart |
| VRSN | ▼ Sell | Open Market | 2,500 | $544K | 3/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
VeriSign Stock Considered Expensive Despite Monopoly
A recent analysis notes that VeriSign’s share price is high relative to its earnings and peers, even though the company holds a dominant position in domain name registration. The stock trades near the top of its 52‑week range and sits above a key support level at $292.94. With a trailing P/E of 32.5 and a modest dividend yield of 1.10%, the valuation is a point of discussion for investors.
VeriSign Stock Considered Expensive Despite Monopoly. A recent analysis notes that VeriSign’s share price is high relative to its earnings and peers, even though the company holds a dominant position in domain name registration. The stock trades near the top of its 52‑week range and sits above a key support level at $292.94. With a trailing P/E of 32.5 and a modest dividend yield of 1.10%, the valuation is a point of discussion for investors.